JP Morgan initiates Definium Therapeutics at Overweight
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
07:21:07 PM UTC
SquawkNews
Definium Therapeutics Initiated at Overweight by JP Morgan
07:21:29 PM UTC
SquawkNews
Definium Therapeutics Price Target Announced at $84.00/Share by JP Morgan